Top Suppliers:I want be here

124751-00-4

124751-00-4 structure
124751-00-4 structure

Name [2-butyl-5-chloro-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
Synonyms Lostan N1-Trityl Impurity
[phenyl-(phenylthio)sulfonyl-methyl]benzene
Enalapril IMpurity H
N-Trithyl Lostan
2-Butyl-4-chloro-1-[(2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl]-1H-imidazol-5-yl]methanol
Allistan Isoproxil INT
N-Trityl Lostan
Trityllostan Discontinued, not on 2 position
2-Butyl-4-chloro-1-[[2'-[1-(triphenylMethyl)-1H-tetrazol-5-yl][1,1'-biphenyl-4-yl]Methyl]-1H-iMidazole-5-Methanol
Trityllosartan
N-Trityl Losartan
(2S)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycbonyl)propyl] amino]propanoyl]pyrrolidine-2-cboxylic acid
(2-BUTYL-4-CHLORO-1-((2'-(1-TRITYL-1H-TETRAAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)METHYL)-1H-IMIDAZOL-5-YL)METHANOL
2-N-Butyl-4-Chloro-5-Hydroxymethyl-1-[[2’(1H-2-Triphenylmethyl-Tetrazol-5-Yl)Biphenyl-4-Yl]Methyl]Imidazole
(2-Butyl-4-chloro-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazol-5-yl)methanol
[phenyl(phenylsulfanylsulfonyl)methyl]benzene
Enalapril IMpurity H (Mixture of IsoMers)
(2-Butyl-4-chloro-1-((2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazol-5-yl)methanol
[2-Butyl-4-chloro-1-[[2'-[2-(triphenylMethyl)-2H-tetrazol-5-yl]biphenyl-4-yl]Methyl]-1H-iMidazol-5-yl]Methanol
Losaint-D
N1-Trityl Lostan
2-Butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-2-triphenylmethyl-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazole
Lostan N-Trithyl Impurity
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]
Density 1.225g/cm3
Boiling Point 856.623ºC at 760 mmHg
Molecular Formula C41H37ClN6O
Molecular Weight 665.22500
Flash Point 471.868ºC
Exact Mass 664.27200
PSA 81.65000
LogP 8.58040
Vapour Pressure 0mmHg at 25°C
Index of Refraction 1.656

~%

124751-00-4 structure

124751-00-4

Literature: US2004/97568 A1, ; Page/Page column 5 ;

~46%

124751-00-4 structure

124751-00-4

Literature: US5128355 A1, ; US 5128355 A

~%

124751-00-4 structure

124751-00-4

Literature: WO2004/66997 A2, ; Page/Page column 46-47 ;

~%

124751-00-4 structure

124751-00-4

Literature: US5298517 A1, ; US 5298517 A

~95%

124751-00-4 structure

124751-00-4

Literature: Journal of Labelled Compounds and Radiopharmaceuticals, , vol. 54, # 12 p. 754 - 757

~33%

124751-00-4 structure

124751-00-4

Literature: EP1833801 B1, ; Page/Page column 14 ;

~%

124751-00-4 structure

124751-00-4

Literature: WO2006/38223 A1, ; Page/Page column 6-7 ;

~%

124751-00-4 structure

124751-00-4

Literature: EP1833801 B1, ; Page/Page column 14 ;

~68%

124751-00-4 structure

124751-00-4

Literature: WO2006/81807 A2, ; Page/Page column 16; 18; 20; 28-29 ;
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.